BRPI1010462A2 - composições que compreendem um inibidor de nfkb e um promotor de colágeno não retinóide - Google Patents

composições que compreendem um inibidor de nfkb e um promotor de colágeno não retinóide

Info

Publication number
BRPI1010462A2
BRPI1010462A2 BRPI1010462A BRPI1010462A BRPI1010462A2 BR PI1010462 A2 BRPI1010462 A2 BR PI1010462A2 BR PI1010462 A BRPI1010462 A BR PI1010462A BR PI1010462 A BRPI1010462 A BR PI1010462A BR PI1010462 A2 BRPI1010462 A2 BR PI1010462A2
Authority
BR
Brazil
Prior art keywords
compositions
collagen promoter
retinoid collagen
nfkb inhibitor
inhibitor
Prior art date
Application number
BRPI1010462A
Other languages
English (en)
Inventor
Michael Southall
Samantha Tucker-Samaras
Simarna Kaur
Thierry Oddos
Original Assignee
Johnson & Johnson Consumer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer filed Critical Johnson & Johnson Consumer
Publication of BRPI1010462A2 publication Critical patent/BRPI1010462A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

composições que compreendem um inibidor de nf?b e um promotor de colágeno não retinoide. a presente invenção refere-se a uma composição que compre- ende um inibidor de nf?b e um promotor de colágeno não retinoide.
BRPI1010462A 2009-10-02 2010-10-01 composições que compreendem um inibidor de nfkb e um promotor de colágeno não retinóide BRPI1010462A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/572,565 US8906432B2 (en) 2009-10-02 2009-10-02 Compositions comprising an NFκB-inhibitor and a non-retinoid collagen promoter

Publications (1)

Publication Number Publication Date
BRPI1010462A2 true BRPI1010462A2 (pt) 2016-11-16

Family

ID=43769145

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1010462A BRPI1010462A2 (pt) 2009-10-02 2010-10-01 composições que compreendem um inibidor de nfkb e um promotor de colágeno não retinóide

Country Status (8)

Country Link
US (2) US8906432B2 (pt)
EP (1) EP2316413B1 (pt)
KR (1) KR101773753B1 (pt)
CN (1) CN102028645B (pt)
BR (1) BRPI1010462A2 (pt)
CA (1) CA2716261C (pt)
ES (1) ES2597978T3 (pt)
RU (1) RU2562140C2 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8906432B2 (en) 2009-10-02 2014-12-09 Johnson & Johnson Consumer Companies, Inc. Compositions comprising an NFκB-inhibitor and a non-retinoid collagen promoter
US8084504B2 (en) 2009-10-02 2011-12-27 Johnson & Johnson Consumer Companies, Inc. High-clarity aqueous concentrates of 4-hexylresorcinol
IN2012DN02441A (pt) * 2009-10-02 2015-08-21 Johnson & Johnson Consumer
US20110081430A1 (en) 2009-10-02 2011-04-07 Simarna Kaur COMPOSITIONS COMPRISING AN NFkB-INHIBITOR AND A TROPOELASTIN PROMOTER
US20140296155A1 (en) * 2011-09-23 2014-10-02 Amy Newburger Anti-stretch mark skin cream and method for making and using thereof
JP5926616B2 (ja) * 2012-05-30 2016-05-25 日清ファルマ株式会社 老化抑制剤
US8846013B2 (en) 2012-06-29 2014-09-30 Johnson & Johnson Consumer Companies, Inc. Topical application of 1-hydroxyl-3,5-BIS(4′hydroxy styryl)benzene
US8758731B2 (en) 2012-06-29 2014-06-24 Johnson & Johnson Consumer Companies, Inc. Skin lightening by topical application of 1-hydroxyl 3,5-bis(4′hydroxyl styryl)benzene
US20140086859A1 (en) 2012-09-24 2014-03-27 Johnson & Johnson Consumer Companies, Inc. Low oil compositions comprising a 4-substituted resorcinol and a high carbon chain ester
KR102160306B1 (ko) * 2013-08-20 2020-09-25 주식회사 알엔에스 피부미백제
US20150272837A1 (en) 2014-03-27 2015-10-01 Johnson & Johnson Consumer Companies, Inc. Topical Compositions Comprising A Resorcinol and Powders
WO2016154362A1 (en) 2015-03-23 2016-09-29 The Brigham And Women's Hospital, Inc. Tolerogenic nanoparticles for treating diabetes mellitus
IT201700104536A1 (it) * 2017-09-19 2019-03-19 Cmed Aesthetics Srl Prodotti topici con sistema bifasico
US20220023172A1 (en) 2018-11-29 2022-01-27 Kristina Trujillo Cosmetic compositions and methods of use

Family Cites Families (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1649670A (en) * 1923-11-08 1927-11-15 Sharp & Dohme Inc Hexyl resorcinol
US2697118A (en) 1953-07-28 1954-12-14 Wyandotte Chemicals Corp Totally hydroxypropylated alkylene diamines
DE1067180B (de) 1956-03-06 1959-10-15 Dr Pierre Soum hautpflegemittel
US3193507A (en) * 1961-08-30 1965-07-06 Henry R Jacobs Method of cleaning glass
US4093667A (en) * 1977-03-14 1978-06-06 Continental Oil Company Preparation of 4-n-hexylresorcinol
US4337370A (en) * 1979-11-08 1982-06-29 Sumitomo Chemical Company, Limited Process for the preparation of resorcinol derivatives
JPH0651619B2 (ja) * 1988-05-09 1994-07-06 株式会社クラレ 美白剤
US5218079A (en) 1990-05-18 1993-06-08 Yale University Soluble melanin
US5227459A (en) 1990-05-18 1993-07-13 Yale University Synthetic melanin
JPH08176004A (ja) 1994-12-21 1996-07-09 Lion Corp 生体老化防止剤及び皮膚用組成物
ES2103198B1 (es) * 1995-08-09 1998-10-01 Cabo Soler Jose Nueva formulacion cosmetica y farmaceutica de antiandrogenos de origen natural (vegetal) para aplicacion topica percutanea.
FR2746008B1 (fr) 1996-03-14 1998-05-29 Composition a usage topique anti-vieillissement
US5705145A (en) * 1996-08-21 1998-01-06 E-L Management Corp. Skin tanning compositions and method
US6071543A (en) 1997-06-02 2000-06-06 Cellegy Pharmaceuticals, Inc. Pyridine-thiols reverse mucocutaneous aging
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
JPH11100324A (ja) 1997-09-29 1999-04-13 Lion Corp ニキビ治療用組成物
JP4004182B2 (ja) 1999-05-24 2007-11-07 ポーラ化成工業株式会社 乳化組成物
US20030003170A1 (en) * 2000-06-02 2003-01-02 Theresa Callaghan Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium)
JP4615671B2 (ja) 2000-04-20 2011-01-19 ポーラ化成工業株式会社 炎症存在下使用用のしわ形成又は皮膚の弾力喪失の防止剤
WO2002003931A2 (en) 2000-07-10 2002-01-17 The Procter & Gamble Company Cosmetic compositions
US20070003536A1 (en) * 2000-11-21 2007-01-04 Zimmerman Amy C Topical skin compositions, their preparation, and their use
CN100539984C (zh) 2001-03-16 2009-09-16 强生消费者公司 含有小白菊提取物的组合物及其用途
DE10118894A1 (de) 2001-04-18 2002-10-24 Goldwell Gmbh Verfahren zum oxidativen Färben von menschlichen Haaren
DE10118889A1 (de) 2001-04-18 2002-10-24 Goldwell Gmbh Haarfärbemittel
US6797697B2 (en) 2001-05-21 2004-09-28 Johnson & Johnson Consumer Companies, Inc. Composition containing a peptide and a pigment and the use thereof in darkening the skin
US7214655B2 (en) 2001-05-21 2007-05-08 Johnson & Johnson Consumer Companies, Inc. Peptides and the use thereof in darkening the skin
DE10157490A1 (de) 2001-11-23 2003-06-05 Beiersdorf Ag Kosmetische und/oder dermatologische Lichtschutzzubereitung
US6863897B2 (en) * 2002-03-22 2005-03-08 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Stabilization of resorcinol derivatives in cosmetic compositions
US6869598B2 (en) * 2002-03-22 2005-03-22 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Stabilization of sunscreens in cosmetic compositions
WO2003082231A2 (en) 2002-03-28 2003-10-09 Johnson & Johnson Consumer Companies, Inc. Compostions for darkening the skin
FR2837700B1 (fr) 2002-03-28 2004-05-28 Oreal Composition cosmetique ou dermatologique contenant l'association d'un tetrahydrocurcuminoide et d'une huile amidee
KR20030089598A (ko) 2002-05-16 2003-11-22 주식회사 태평양 자유라디칼 소거능 또는 세포내 항산화계에 대한 보호능이있는 피부 외용제 조성물
US7025951B2 (en) 2002-06-18 2006-04-11 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for darkening the skin
US6852310B2 (en) * 2002-08-23 2005-02-08 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Skin lightening agents, compositions and methods
JP3962666B2 (ja) 2002-09-13 2007-08-22 株式会社クラレ 皮膚外用剤
US6926886B2 (en) 2002-10-31 2005-08-09 Johnson & Johnson Consumer Companies, Inc. Compositions for darkening the skin and/or hair
US20040109832A1 (en) * 2002-12-09 2004-06-10 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Di-substituted resorcinols as skin lightening agents
FR2848116B1 (fr) 2002-12-10 2007-01-05 Nuxe Lab Composition cosmetique comprenant un inhibiteur des metallo-proteinases et un lipopeptide.
US6875425B2 (en) 2002-12-12 2005-04-05 Unilever Home & Personal Care Usa Skin lightening agents, compositions and methods
US20040156873A1 (en) 2003-02-10 2004-08-12 Gupta Shyam K. Topically Bioavailable Acne and Rosacea Treatment Compositions
GB2398496A (en) * 2003-02-20 2004-08-25 Reckitt Benckiser Healthcare Suspensions of water-swellable polymer particles which are substantially water-free or contain insufficient water to fully swell the particles
EP1613295A1 (en) * 2003-04-15 2006-01-11 Unilever N.V. Use of alkyl resorcinols in the treatment of acne
DE10324566A1 (de) 2003-05-30 2004-12-16 Symrise Gmbh & Co. Kg Verwendung von Diphenylmethan-Derivaten als Tyrosinase-Inhibitoren
GB2438999B (en) 2003-06-13 2008-01-16 Engelhard Lyon Stimulation of the synthesis and of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibres
US7320797B2 (en) * 2003-08-29 2008-01-22 Bioderm Research Antiaging cosmetic delivery systems
GB2415135A (en) * 2004-06-15 2005-12-21 Reckitt Benckiser Improvements in and relating to depilatory compositions
JP4927718B2 (ja) 2004-06-18 2012-05-09 シムライズ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・コンパニー・コマンジツト・ゲゼルシヤフト ブラックベリー抽出物
US20060019002A1 (en) * 2004-07-26 2006-01-26 Harvest Food Co., Ltd. Method for processing, storing and transporting garlic
US20060088608A1 (en) * 2004-10-26 2006-04-27 Miri Seiberg Compositions containing cotinus coggygria extract and use thereof on skin and mucosal tissues
US20060120975A1 (en) * 2004-12-02 2006-06-08 Colgate-Palmolive Company Oral care composition comprising a phenolic compound and antioxidant vitamins and vitamin derivatives
TW200637585A (en) * 2004-12-24 2006-11-01 Unilever Nv Improved cleansing composition
US8278359B2 (en) * 2005-02-25 2012-10-02 Johnson & Johnson Consumer Companies, Inc. Compositions containing amines and use thereof to treat acne or reduce the appearance of oil or pores on the skin
US20060210497A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives
US20060210498A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives for skin
EP1865929A2 (en) * 2005-03-28 2007-12-19 Bioresponse, L.L.C. Diindolylmethane-based compositions and methods of use thereof for promoting oral mucosal and bone health
BRPI0610180A2 (pt) 2005-05-24 2012-09-25 Wellgen Inc métodos para prevenir, para tratar, e para tratar ou controlar uma condição associada à inflamação
JP2006327965A (ja) 2005-05-25 2006-12-07 Pola Chem Ind Inc 皮膚外用剤とその適用
WO2007021240A1 (en) 2005-08-18 2007-02-22 Tricutan Ab New skin improving composition
DE602005013788D1 (de) 2005-10-11 2009-05-20 ckrox-Peptide und ihre Analoge zur Behandlung von Hautalterung
US20070156873A1 (en) * 2005-12-30 2007-07-05 O'neil Douglas Methods, systems, and products for provisioning communications services
WO2007089267A1 (en) * 2006-02-03 2007-08-09 Jr Chem, Llc Anti-aging treatment using copper and zinc compositions
KR20080112229A (ko) 2006-02-14 2008-12-24 포라 가세이 고교 가부시키가이샤 미백용 화장료
US7537791B2 (en) * 2006-02-21 2009-05-26 Integrated Botanical Technologies, Llc Parthenolide free bioactive ingredients from feverfew (Tanacetum parthenium) and processes for their production
JP2007254412A (ja) 2006-03-24 2007-10-04 Kuraray Co Ltd シワの予防及び／又は改善のための皮膚外用剤
FR2898903B1 (fr) * 2006-03-24 2012-08-31 Oreal Composition de teinture comprenant un colorant disulfure fluorescent, procede d'eclaircissement des matieres keratiniques a partir de ce colorant
CA2655788C (en) 2006-06-19 2014-03-18 Kuraray Co., Ltd. Skin external preparation containing triterpenic acid
JP2007332116A (ja) 2006-06-19 2007-12-27 Kuraray Co Ltd 有色芳香族キノン誘導体を含有する皮膚外用剤
WO2008012922A1 (en) 2006-07-25 2008-01-31 Shiseido Company, Ltd. Powdery cosmetic
US20080026974A1 (en) * 2006-07-27 2008-01-31 Barnhart Ronald A Antimicrobial hand wash
TW200809924A (en) * 2006-08-09 2008-02-16 Kinik Co Chemical vapor thin film deposition device
US20100124539A1 (en) * 2006-10-16 2010-05-20 Hanson Medical, Inc. Cosmetic preparations
JP5015620B2 (ja) 2007-01-30 2012-08-29 株式会社クラレ 皮膚外用剤
US20080241085A1 (en) 2007-03-29 2008-10-02 Lin Connie B Compositions for use in darkening the skin
EP2144590B1 (en) 2007-05-14 2018-08-01 Sytheon Ltd. Skin treatment compositions and methods
US20080286217A1 (en) * 2007-05-14 2008-11-20 Chaudhuri Ratan K Sunscreen compositions and methods
US20090075902A1 (en) 2007-05-25 2009-03-19 Robbins Paul D Inhibiting the signs of aging by inhibiting nf-kappa b activation
US20080305059A1 (en) * 2007-06-06 2008-12-11 Chaudhuri Ratan K Skin lightening compositions and methods
EP2170324A4 (en) * 2007-06-21 2010-11-03 Puramed Bioscience Inc COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING MIGRAINE HEADACHE AND ASSOCIATED SYMPTOMS
JP2009084164A (ja) 2007-09-27 2009-04-23 Septem Soken:Kk 老化防止剤
US20090087395A1 (en) 2007-10-01 2009-04-02 Lin Connie B Compositions for use in darkening the skin
CA2706797A1 (en) 2007-11-19 2009-05-28 Stiefel Laboratories, Inc. Topical cosmetic skin lightening compositions and methods of use thereof
US8632816B2 (en) 2007-12-17 2014-01-21 Elc Management, Llc Compositions comprising solid particles entrapped in collapsed polymeric microspheres, and methods of making the same
US20110171288A1 (en) * 2008-02-20 2011-07-14 Fatemeh Mohammadi Topical compositions and methods for whitening skin
EP2100594A1 (de) 2008-03-14 2009-09-16 Symrise GmbH & Co. KG Ternäre Mischungen mit Collagensynthese steigernder Wirkung
TWI414317B (zh) 2008-05-29 2013-11-11 資生堂股份有限公司 皮膚外用劑
US9676696B2 (en) * 2009-01-29 2017-06-13 The Procter & Gamble Company Regulation of mammalian keratinous tissue using skin and/or hair care actives
EP2250995B1 (en) 2009-05-15 2020-01-15 Merck Patent GmbH Pigment mixtures
IN2012DN02441A (pt) * 2009-10-02 2015-08-21 Johnson & Johnson Consumer
US20110081430A1 (en) 2009-10-02 2011-04-07 Simarna Kaur COMPOSITIONS COMPRISING AN NFkB-INHIBITOR AND A TROPOELASTIN PROMOTER
US8084504B2 (en) 2009-10-02 2011-12-27 Johnson & Johnson Consumer Companies, Inc. High-clarity aqueous concentrates of 4-hexylresorcinol
US8906432B2 (en) 2009-10-02 2014-12-09 Johnson & Johnson Consumer Companies, Inc. Compositions comprising an NFκB-inhibitor and a non-retinoid collagen promoter
US20110081305A1 (en) * 2009-10-02 2011-04-07 Steven Cochran Compositions comprising a skin-lightening resorcinol and a skin darkening agent
DE102010044956B4 (de) 2010-09-10 2012-05-24 Merck Patent Gmbh Goniochromatisches Messverfahren zur Charakterisierung von Pigmenten und Füllstoffen
US8895628B2 (en) 2010-10-25 2014-11-25 Johnson & Johnson Consumer Companies, Inc. Compositions comprising a retinoid and an NFkB-inhibitor and their methods of use
JP5291729B2 (ja) 2011-02-07 2013-09-18 株式会社 資生堂 日焼け止め化粧料
US9271921B2 (en) 2011-12-14 2016-03-01 Avon Products, Inc. Cosmetic compositions having persistent tightening effects
US20140086859A1 (en) 2012-09-24 2014-03-27 Johnson & Johnson Consumer Companies, Inc. Low oil compositions comprising a 4-substituted resorcinol and a high carbon chain ester
US20150272837A1 (en) 2014-03-27 2015-10-01 Johnson & Johnson Consumer Companies, Inc. Topical Compositions Comprising A Resorcinol and Powders

Also Published As

Publication number Publication date
CA2716261A1 (en) 2011-04-02
EP2316413A3 (en) 2013-05-22
US20110081431A1 (en) 2011-04-07
CN102028645A (zh) 2011-04-27
RU2010140351A (ru) 2012-04-10
CN102028645B (zh) 2014-10-15
KR20110036682A (ko) 2011-04-08
RU2562140C2 (ru) 2015-09-10
EP2316413A2 (en) 2011-05-04
KR101773753B1 (ko) 2017-09-01
CA2716261C (en) 2017-09-19
US20130164393A1 (en) 2013-06-27
ES2597978T3 (es) 2017-01-24
US9289361B2 (en) 2016-03-22
US8906432B2 (en) 2014-12-09
EP2316413B1 (en) 2016-07-20

Similar Documents

Publication Publication Date Title
BR112013007362A2 (pt) composição farmacêutica
MX356282B (es) Composiciones y metodos que comprenden variantes de proteasa.
EP2316413A3 (en) Compositions comprising an nfkb-inhibitor and a non-retinoid collagen promoter
EP2443193A4 (en) HARDENABLE FLUORELASTOMER COMPOSITIONS
BRPI1009190A2 (pt) composições aditivas espessantes
BRPI0822622A2 (pt) Uma composição que contém levedura usada para aditivo de alimento de bovinos
BRPI0915341A2 (pt) artigo absorvente que compreende uma região ativada
BR112012003977A2 (pt) composições que induzem ajuda de célula t
CR20110467A (es) Derivados de benzofuranilo como inhibidores de la glucoquinasa
BRPI1010795A2 (pt) compostos antivirais
MX2011007709A (es) Composicion decapante.
BRPI1012285A2 (pt) composições de resinas que compreendem derivados de lignina
EP2495286A4 (en) HARDENING COMPOSITION
EP2246393A4 (en) HARDENING COMPOSITION
BR112012001798A2 (pt) composição de limpeza que proporciona benefícios residuais
BRPI0908265A2 (pt) Composição de limpeza que proporciona vantagens residuais
BRPI0822882A2 (pt) Composição curável
BRPI0914940A8 (pt) Composições nutritivas contendo punicalaginas
EP4534115A3 (en) Injectable biomaterials
MX2011013661A (es) Composiciones y metodos para el tratamiento de esclerosis multiple.
EP2248835A4 (en) HARDENING COMPOSITION
BR112012000145A2 (pt) construção de uma passarela
BR112013008368A2 (pt) composição de polímero
WO2010119455A3 (en) An injectable sustained release pharmaceutical composition
EP2424918A4 (en) HARDENING ACCELERATOR FOR ANAEROBIC HARDENABLE COMPOSITIONS

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 8/34 (2006.01), A61K 8/97 (2006.01), A61Q 19/

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 10A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2599 DE 27-10-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.